Delivery Order SPE2DR25D3501-SPE2DR26FM0AF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,197.26 to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Losartan-HCTZ 100-25 mg tablets (90-count). The contract, which is a firm fixed-price delivery order with a completion date of December 1, 2025, was awarded through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location in the...
- The Defense Logistics Agency awarded a $3,671.46 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count bottles). This firm fixed-price delivery order, with completion scheduled for December 3, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,184.89 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-25 mg tablets in a 90-count package. The contract was executed on December 3, 2025, with an ultimate completion date of December 4, 2025, and operates under firm fixed-price terms with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's primary...
- The Defense Logistics Agency awarded a $1,033.08 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count). This competitively awarded, firm fixed-price contract is scheduled for completion by December 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a 90-count quantity, with a ceiling value of $1,867.39. This firm fixed-price delivery order has an ultimate completion date of October 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) at a ceiling value of $13,135.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract has an ultimate completion date of December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,662.10 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-25 mg tablets (90-count) on November 18, 2025, with completion expected by November 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count supply) with a ceiling value of $4,599.60. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of December 12, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,934.36 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) on September 16, 2025. This firm fixed price delivery order, with a completion date of September 17, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. The pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $5,693.71 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-25 mg tablets (90-count units) under a firm fixed price arrangement. This non-competitive delivery order, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply support to the federal government. The order will be fulfilled from the vendor's...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FM0AFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,929.68 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Losartan-HCTZ 100-25 mg tablets in a 90-day supply. This competitive, firm fixed-price delivery order is scheduled for completion by December 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under the company's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves as a prime supplier to the Defense Logistics Agency's Medical Supply Chain and supports military healthcare systems across multiple therapeutic domains. This delivery order supports DLA's pharmaceutical supply requirements, with the medication fulfilling healthcare needs within the military medical supply system. The award was made through open competition with no set-aside designation, consistent with AmerisourceBergen's established track record of competitively awarded contracts ranging from small-value transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 12/4/25 |